Literature DB >> 1688578

Transforming growth factor beta 1 has differential effects on B cell proliferation and activation antigen expression.

D Cross1, J C Cambier.   

Abstract

There is accumulating evidence that TGF beta 1 is an important immunoregulatory molecule. Here we report evidence that TGF beta 1 has potent effects on murine B cells. It is profoundly inhibitory to the proliferation of quiescent B cells activated in model systems using both thymus-independent and thymus-dependent stimuli and arrests cells predominantly at the G1 cell-cycle stage. It also blocks the proliferation of B cell blasts, with a similar accumulation at stage G1. In parallel with this antiproliferative effect, TGF beta 1 inhibits induction of the expression of a series of "activation Ag" including transferrin receptor, RL388, and Ly-6, in mitogen-stimulated B cells. It also inhibits the induction of Ly-6 expression by IL-4, a nonmitogenic stimulus. In contrast to these negative influences, TGF beta 1 induces modestly increased expression of MHC class II Ag in quiescent B cells, and more marked increases in both B cell blasts and mitogen-stimulated cells. We speculate that in the appropriate context TGF beta 1 may be a cytokine that promotes productive B cell-Th cell interaction.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1688578

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

1.  Redirection of B cell responsiveness by transforming growth factor beta receptor.

Authors:  Jurgen Roes; B Ken Choi; Balthazar B Cazac
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-28       Impact factor: 11.205

2.  Transforming growth factor-beta in a model of IgA switching.

Authors:  D Y Kunimoto
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

3.  Inhibition of CD1d-mediated antigen presentation by the transforming growth factor-β/Smad signalling pathway.

Authors:  Jennifer C Bailey; Abhirami K Iyer; Gourapura J Renukaradhya; Yinling Lin; Hoa Nguyen; Randy R Brutkiewicz
Journal:  Immunology       Date:  2014-12       Impact factor: 7.397

4.  Further Characterization of Activin A-induced IgA Response in Murine B Lymphocytes.

Authors:  Hwa-Joung Lee; Pyeung-Hyeun Kim
Journal:  Immune Netw       Date:  2009-08-31       Impact factor: 6.303

5.  Splenic T-lymphocyte functions during early syphilitic infection are complex.

Authors:  T J Fitzgerald; M A Tomai
Journal:  Infect Immun       Date:  1991-11       Impact factor: 3.441

6.  Systemic immunological effects of cytokine genes injected into skeletal muscle.

Authors:  E Raz; A Watanabe; S M Baird; R A Eisenberg; T B Parr; M Lotz; T J Kipps; D A Carson
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-15       Impact factor: 11.205

7.  Transforming growth factor beta 1 (TGF-beta 1) induced neutrophil recruitment to synovial tissues: implications for TGF-beta-driven synovial inflammation and hyperplasia.

Authors:  R A Fava; N J Olsen; A E Postlethwaite; K N Broadley; J M Davidson; L B Nanney; C Lucas; A S Townes
Journal:  J Exp Med       Date:  1991-05-01       Impact factor: 14.307

8.  A transforming growth factor beta 2 (TGF-beta 2)-like immunosuppressive factor in amniotic fluid and localization of TGF-beta 2 mRNA in the pregnant uterus.

Authors:  D J Altman; S L Schneider; D A Thompson; H L Cheng; T B Tomasi
Journal:  J Exp Med       Date:  1990-11-01       Impact factor: 14.307

9.  Interleukin 10, a novel B cell stimulatory factor: unresponsiveness of X chromosome-linked immunodeficiency B cells.

Authors:  N F Go; B E Castle; R Barrett; R Kastelein; W Dang; T R Mosmann; K W Moore; M Howard
Journal:  J Exp Med       Date:  1990-12-01       Impact factor: 14.307

10.  Mice from a genetically resistant background lacking the interferon gamma receptor are susceptible to infection with Leishmania major but mount a polarized T helper cell 1-type CD4+ T cell response.

Authors:  K Swihart; U Fruth; N Messmer; K Hug; R Behin; S Huang; G Del Giudice; M Aguet; J A Louis
Journal:  J Exp Med       Date:  1995-03-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.